Adoption of the new 2017 American College of Cardiology/American Heart Association (ACC/AHA) hypertension guidelines would be associated with a substantial increase in the prevalence of hypertension and the number of people treated with drugs in both the US and China, a recent study found. Researchers analyzed data from the US National Health and Nutrition Examination Survey (NHANES) for the most recent 2 cycles (2013-2014, 2015-2016) and China Health and Retirement Longitudinal Study (CHARLS) (2011-2012). Participants included all adults aged 45-75 who would have a diagnosis of hypertension and be candidates for treatment on the basis of the ACC/AHA guidelines, compared with current guidelines. Among the findings:
- The number of people labeled as having hypertension in the US and China would increase by 26.8% and 45.1%, respectively.
- In the US and China, respectively, 7.5 million and 55.3 million people would be newly recommended for antihypertensive treatment.
- Another 13.9 million and 30 million, respectively, would be newly recommended for intensification of treatment.
Khera R, Lu Y, Lu J, et al. Impact of 2017 ACC/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: Nationally representative cross sectional study. [Published online ahead of print July 11, 2018]. BMJ. doi:10.1136/bmj.k2357.
This Week's Must Reads
Tdap Immunization & Neonatal Pertussis Antibodies, JAMA; 2018 Oct 9; Healy, Rench, et al
Influenza Vaccine Effectiveness During Pregnancy, Clin Infect Dis; ePub 2018 Oct 11; Thompson, et al
Vaccination Coverage & Exemption Rates in Children, MMWR; 2018 Oct 12; Mellerson, Maxwell, et al
Severe Pertussis Infections in All Age Groups, Clin Infect Dis; ePub 2018 Oct 15; Mbayei, et al
Influenza Vaccine Type Preference Among Parents, Vaccine; ePub 2018 Oct 16; Santibanez, et al
Must Reads in Cardiology
Treating Low-Risk Patients with Mild Hypertension, JAMA Intern Med; ePub 2018 Oct 29; Sheppard, et al
Concomitant DOAC-Antiplatelet Use & Bleeding Risk, Am J Med; ePub 2018 Oct 25; Douros, et al
Omega 3 Polyunsaturated Fatty Acids & Healthy Aging, BMJ; ePub 2018 Oct 17; Lai, Otto, et al
Kidney Damage Biomarkers & Incident CKD in BP Reduction, Ann Intern Med; ePub 2018 Oct 23; Zhang, et al
Excess Hypertension Risk in Black Adults, JAMA; 2018 Oct 8; Howard, Cushman, et al